Cite
MLA Citation
M. Geller et al.. “SAT0479 Early Findings from Prolia® Post-Marketing Safety Surveillance for Atypical Femoral Fracture, Osteonecrosis of the Jaw, Severe Symptomatic Hypocalcemia, and Anaphylaxis.” Annals of the rheumatic diseases, vol. 73, 2014, pp. 766–767. http://access.bl.uk/ark:/81055/vdc_100135158732.0x00005a